These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 6807705)

  • 41. [The significance of incorrect spray technic on the consumption of terbutaline in patients with chronic obstructive lung disease].
    Ibsen TB; Svendsen UG
    Ugeskr Laeger; 1990 May; 152(19):1375-8. PubMed ID: 2188408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aerosol therapy in adult lung disease.
    Newhouse M
    Arch Monaldi; 1984; 39(3):107-14. PubMed ID: 6536224
    [No Abstract]   [Full Text] [Related]  

  • 43. [Physiotherapy and aerosols with intermittent positive pressure in the rehabilitation of chronic obstructive lung diseases].
    Herzog H; Perruchoud A
    Poumon Coeur; 1977; 33(1):79-86. PubMed ID: 327463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deposition of pressurised aerosols in the human respiratory tract.
    Newman SP; Pavia D; Morén F; Sheahan NF; Clarke SW
    Thorax; 1981 Jan; 36(1):52-5. PubMed ID: 7292382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measuring human mucociliary clearance].
    Stahlhofen W; Scheuch G
    Pneumologie; 1990 Feb; 44 Suppl 1():422-3. PubMed ID: 2367426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mode of inhalation for trained and untrained asthmatics using a pressurized aerosol.
    Morén F; Andersson J; Stiksa G
    Respiration; 1984; 45(1):56-60. PubMed ID: 6689798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies on the onset of effect of reproterol following inhalation from a metered aerosol (author's transl)].
    Mándi A; Wilde W; Galgóczy G; Aurich R; Galambos E
    Arzneimittelforschung; 1977; 27(12):64-6. PubMed ID: 576834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease.
    Kim CS; Kang TC
    Am J Respir Crit Care Med; 1997 Mar; 155(3):899-905. PubMed ID: 9117024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respiratory deposition model of an inhaled aerosol bolus.
    Huang CW; Pei C; Huang CH
    Comput Methods Biomech Biomed Engin; 2011 Oct; 14(10):915-25. PubMed ID: 21409658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological variability of regional deposition of aerosol particles in the human respiratory tract.
    Stahlhofen W; Gebhart J; Heyder J
    Am Ind Hyg Assoc J; 1981 May; 42(5):348-52. PubMed ID: 7223643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new inhalation technique for freon aerosols. Terbutaline aerosol with a tube extension in a 2-day cross-over comparison with salbutamol aerosol.
    Eriksson NE; Haglind K; Hidinger KG
    Allergy; 1980 Oct; 35(7):617-22. PubMed ID: 7468948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Terbutaline aerosol from a metered dose inhaler with a 750-ml spacer or as a nebulized solution. Comparison of two delivery systems for bronchodilator aerosol.
    Stauder J; Hidinger KG
    Respiration; 1983; 44(3):237-40. PubMed ID: 6857008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retention of particles inhaled in boli with and without induced bronchoconstriction.
    Scheuch G; Philipson K; Falk R; Anderson M; Svartengren M; Stahlhofen W; Camner P
    Exp Lung Res; 1995; 21(6):901-16. PubMed ID: 8591793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary studies with a breath actuated bronchodilator aerosol device.
    McIlreath FJ; Cohen BM
    J Med; 1970; 1(4):229-35. PubMed ID: 5280161
    [No Abstract]   [Full Text] [Related]  

  • 55. [Investigating the possibility of aerosol therapy individualization using the stochastic lung model].
    Brâzaniuc K; Sárkány Z; Copotoiu SM; Măruşteri M; Azamfirei L; Kinga B; Balásházy I
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):295-8. PubMed ID: 17802934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deposition of inspired aerosol particles within the respiratory tract of patients with obstructive lung disease.
    Schiller-Scotland CF; Gebhart J; Hochrainer D; Siekmeier R
    Toxicol Lett; 1996 Nov; 88(1-3):255-61. PubMed ID: 8920746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aerosol therapy of patients with lung diseases].
    Kokosov AN; Potashev DA
    Klin Med (Mosk); 1988 Dec; 66(12):108-13. PubMed ID: 3230841
    [No Abstract]   [Full Text] [Related]  

  • 58. Deposition of Particles in the Alveolar Airways: Inhalation and Breath-Hold with Pharmaceutical Aerosols.
    Khajeh-Hosseini-Dalasm N; Longest PW
    J Aerosol Sci; 2015 Jan; 79():15-30. PubMed ID: 25382867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accumulation and retention of 137Cs-labelled fused aluminosilicate particles by beagle dogs after repeated inhalation exposures.
    Boecker BB; Thomas RG; McClellan RO
    Inhaled Part; 1975 Sep; 4 Pt 1():221-36. PubMed ID: 1236158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of dosage-aerosols in the treatment of obstructive respiratory tract diseases].
    Frank A
    Wien Med Wochenschr; 1977 May; 127(10):309-13. PubMed ID: 141791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.